Draeger, Inc. recalled 188 units of the Vapor 3000 anesthetic vaporizer on November 24, 2025. The devices contained impurities in a component not delivered within specification. Healthcare providers and patients must stop using the devices immediately.
A certain component of affected devices was not delivered within specification and contained impurities.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Draeger, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recall affects the Draeger Vapor 3000 anesthetic vaporizer, model number M36500. These devices were distributed worldwide, including across 13 U.S. states such as California and New York. The quantity recalled is 188 units.
The recalled anesthetic vaporizer contains a component that does not meet specifications and includes impurities, which may pose health risks to patients. The situation has been classified as a Class I recall, indicating a high risk of serious injury.
There are no reported incidents or injuries associated with the recall at this time. However, the potential risks from impurities could lead to serious health complications.
Stop using the Draeger Vapor 3000 anesthetic vaporizer immediately. Follow the recall instructions provided by the manufacturer and contact Draeger, Inc. or your healthcare provider for further instructions.
For more information, contact Draeger, Inc. directly. Visit their website or call their customer service for assistance.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.